ReviewCurrent allergy and asthma reports2014
Indications for surgery in refractory rhinitis.
Review in Current allergy and asthma reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 6 citations in OpenAlex.
- Imaging anatomy of the vidian canal and its clinical significance.Quantitative imaging in medicine and surgery · 2023Article
- Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis.Allergy, asthma & immunology research · 2018Review
- Clinical assessment of diode laser-assisted endoscopic intrasphenoidal vidian neurectomy in the treatment of refractory rhinitis.Lasers in medical science · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medical treatment of chronic rhinitis is successful in a majority of patients, but there is a still large population of patients who fail medical therapy. Surgical treatment for patients with severe persistent allergic rhinitis is not a new solution, but recent advancements in technology and surgical technique have made surgery safer and more effective. There is no gold standard of treatment in patients with refractory rhinitis, and surgeons may select a variety of procedures and techniques based on a patient's anatomy, severity of disease, and comorbidities. Unfortunately, there are currently few large prospective, randomized controlled trials evaluating surgical treatments, and no study to date has compared immunotherapy to surgical intervention. Therefore, there is no hard and fast rule as to when to pursue surgical intervention after initial medical therapy has failed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.